ARVIND GADEKAR
YOU?
Author Swipe
View article: Effectiveness and safety of clobazam as add-on therapy in children after the failure of first antiseizure medicine: a sub-analysis of the ADD-ON study
Effectiveness and safety of clobazam as add-on therapy in children after the failure of first antiseizure medicine: a sub-analysis of the ADD-ON study Open
CTRI/2017/12/010906.
View article: Multicenter, Phase 4 Clinical Study from India to Evaluate the Safety and Efficacy of Insulin Glargine 300 U/ml in Insulin-Naïve People with Type 2 Diabetes Uncontrolled on Oral Anti-hyperglycemic Drugs: SAFEGUARD Study
Multicenter, Phase 4 Clinical Study from India to Evaluate the Safety and Efficacy of Insulin Glargine 300 U/ml in Insulin-Naïve People with Type 2 Diabetes Uncontrolled on Oral Anti-hyperglycemic Drugs: SAFEGUARD Study Open
Clinical Trials Registry-India (CTRI number): CTRI/2021/07/035244. WHO identifier number: U1111-1255-5143. NCT number: NCT04980027.
View article: The <scp>LongitudinAl</scp> Nationwide <scp>stuDy</scp> on Management And Real‐world <scp>outComes</scp> of diabetes in India over 3 years (<scp>LANDMARC</scp> trial)
The <span>LongitudinAl</span> Nationwide <span>stuDy</span> on Management And Real‐world <span>outComes</span> of diabetes in India over 3 years (<span>LANDMARC</span> trial) Open
Introduction LANDMARC (CTRI/2017/05/008452), a prospective, observational real‐world study, evaluated the occurrence of diabetes complications, glycemic control and treatment patterns in people with type 2 diabetes mellitus (T2DM) from pan…
View article: <p>Cost–benefit comparison of liraglutide and sitagliptin in the treatment of type 2 diabetes in Thailand</p>
Cost–benefit comparison of liraglutide and sitagliptin in the treatment of type 2 diabetes in Thailand Open
The clinical benefits of liraglutide (HbA1c<7.0%, no hypoglycemia, no weight gain, reduced cardiovascular outcomes) partly offset its high price. Therefore, liraglutide should be considered as an appropriate treatment alternative to sitagl…
View article: Hypoglycaemia among Insulin-Treated Patients with Diabetes: Southeast Asia Cohort of IO HAT Study
Hypoglycaemia among Insulin-Treated Patients with Diabetes: Southeast Asia Cohort of IO HAT Study Open
Incidence of any and severe hypoglycaemia in the Southeast Asian cohort of IO HAT was higher prospectively versus retrospectively, suggesting hypoglycaemia has previously been under-reported in this region.
View article: Self-Reported Hypoglycemia in Insulin-Treated Patients with Diabetes: Results from the Philippines Cohort of the International Operations Hypoglycemia Assessment Tool (IO HAT) Study
Self-Reported Hypoglycemia in Insulin-Treated Patients with Diabetes: Results from the Philippines Cohort of the International Operations Hypoglycemia Assessment Tool (IO HAT) Study Open
Among insulin-treated patients, higher rates of hypoglycemia were reported prospectively than retrospectively. This indicates that the patients in real-life setting often under-report hypoglycemia. Patient education can help in accurate re…
View article: A Cross-sectional Study to Evaluate Diabetes Management, Control and Complications in Patients with type 2 Diabetes in Bangladesh
A Cross-sectional Study to Evaluate Diabetes Management, Control and Complications in Patients with type 2 Diabetes in Bangladesh Open
Background: Management of type 2 diabetes is not uniform. The aim of the study was to assess diabetes care delivery and status of long-term diabetes related complications.Methods: DiabCare is an observational, non-interventional, cross-sec…